Skip to content

Liu Shoushan's Tendon Injury Manipulation for Postoperative Pain in Lumbar Spinal Stenosis: A Randomized Controlled Trial?

Liu Shoushan's Tendon Injury Manipulation for Postoperative Pain in Lumbar Spinal Stenosis: A Randomized Controlled Trial?

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002495
Enrollment
Unknown
Registered
2025-12-24
Start date
2025-12-31
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain after lumbar spinal stenosis surgery

Interventions

Treatment group:Postoperative application of Liu Shou Shan's Jinshang technique and Celecoxib capsules.
Control Group:Celecoxib capsules are administered postoperatively.

Sponsors

Dongzhimen Hospital Afliated to Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 79 Years

Inclusion criteria

Inclusion criteria: 1 Simultaneously meeting the diagnostic criteria of both traditional Chinese medicine and Western medicine, and the surgery is performed by a doctor within the same treatment team; 2) Patients with normal mental status, aged between 50 and 79 years (inclusive), of any gender, with a body mass index (BMI) < 30 kg/m²; 3) Volunteers who are willing to participate, able to understand this study, and willing to sign the informed consent form..

Exclusion criteria

Exclusion criteria: 1. Contraindications for massage therapy, such as tumors of the vertebrae or intraspinal tumors, tuberculosis, and severe osteoporosis; individuals with skin damage or dermatological conditions on the back or lower limbs that affect massage procedures; 2. Allergies or contraindications to non-steroidal anti-inflammatory drugs (NSAIDs) or opioid medications; 3. Patients with lumbar disc herniation accompanied by cauda equina nerve injury; 4. Individuals with severe cardiovascular, cerebrovascular, hepatic, renal, or hematological diseases involving other critical organs; 5. History of open lumbar surgery, fractures, or lumbar infections; 6. Use of centrally acting analgesics, NSAIDs, gabapentinoids, glucocorticoids, or immunosuppressive drugs within the four weeks prior to the procedure.

Design outcomes

Primary

MeasureTime frame
ODI scoring;

Secondary

MeasureTime frame
JOA score;VAS score;Soft tissue tension value;Lumbar spine flexion-extension range of motion;

Countries

China

Contacts

Public ContactYu Xing

Dongzhimen Hospital Afliated to Beijing University of Chinese Medicine

yuxingbucm@sina.com19801206692

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026